✦ LIBER ✦

From Cocaine to Innovative Antiemetics. Medicinal Chemistry of 5-HT3 Receptor Antagonists

✍ Scribed by Heiko Zettl; Manfred Schubert-Zsilavecz; Carsten D. Siebert

Publisher: John Wiley and Sons
Year: 2007
Weight: 11 KB
Volume: 38
Category: Article
ISSN: 0931-7597
DOI: 10.1002/chin.200747269

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Pharmacology of the human metabolites of

Pharmacology of the human metabolites of dolasetron, an antiemetic 5-HT3 receptor antagonist

✍ Marc Bigaud; Jack Elands; Philip R. Kastner; Rick A. Bohnke; Lee W. Emmert; Mart 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 English ⚖ 699 KB

ChemInform Abstract: Medicinal Chemistry

ChemInform Abstract: Medicinal Chemistry Research for a Discovery of Ramosetron Hydrochloride as a Novel Serotonine (5-HT3) Receptor Antagonist

✍ Mitsuaki Ohta 📂 Article 📅 2010 🏛 John Wiley and Sons ⚖ 28 KB 👁 1 views

## Abstract ChemInform is a weekly Abstracting Service, delivering concise information at a glance that was extracted from about 100 leading journals. To access a ChemInform Abstract of an article which was published elsewhere, please select a “Full Text” option. The original article is trackable v

Synthesis and structural, conformational

Synthesis and structural, conformational, biochemical, and pharmacological study of new compounds derived from tropane-3-spiro4′(5′)-imidazoline as potential 5-HT3 receptor antagonists

✍ B. A. Whelan; I. Iriepa; E. Galvez; A. Orjales; A. Berisa; L. Labeaga; A. G. Gar 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 English ⚖ 660 KB

A randomized, multicenter study comparin

A randomized, multicenter study comparing the efficacy and tolerability of tropisetron, a new 5-HT3 receptor antagonist, with a metoclopramide-containing antiemetic cocktail in the prevention of cisplatin-induced emesis

✍ Bengt G. Sorbe; Thomas Högberg; Bengt Glimelius; Margareta Schmidt; Lars Wernste 📂 Article 📅 1994 🏛 John Wiley and Sons 🌐 English ⚖ 900 KB

Antiemetic efficacy of the neurokinin-1

Antiemetic efficacy of the neurokinin-1 antagonist, aprepitant, plus a 5HT3 antagonist and a corticosteroid in patients receiving anthracyclines or cyclophosphamide in addition to high-dose cisplatin : Analysis of combined data from two phase III randomized clinical trials

✍ Richard J. Gralla; Ronald de Wit; Jorn Herrstedt; Alexandra D. Carides; Juliana 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 106 KB

Use of 5-HT3 receptor antagonists to pre

Use of 5-HT3 receptor antagonists to prevent nausea and emesis caused by chemotherapy for patients with breast carcinoma in community practice settings

✍ Jane T. Hickok; Joseph A. Roscoe; Gary R. Morrow; Robert M. Stern; Bo Yang; Patr 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 92 KB 👁 2 views

## BACKGROUND. Although 5-HT 3 receptor antagonists are clinically more effective in controlling emesis, particularly that caused by high dose cisplatin, than previously available agents, they appear to be less effective against nausea. This report focuses on the effectiveness of these agents again